Fight Colorectal Cancer Heads to Minnesota for Pitch for Prevention

FOR IMMEDIATE RELEASE National March Against Colorectal Cancer Heads to Minnesota Twins’ Target Field for Pitch for Prevention Fight Colorectal Cancer’s coast-to-coast colorectal cancer awareness campaign, One Million Strong, is collaborating with Mayo Clinic and prostate cancer group Ed Randall’s Fans for the Cure to raise awareness of ‘below the belt’ cancers at Target Field July…  Read More

Avastin Users Wanted for New Research Study

Fight Colorectal Cancer is partnering together with 23andme and Genentech to help researchers better understand if patients’ genes play a role in how they respond to treatments they receive for their colorectal cancer.  This provides patients a new opportunity to participate in genetics research. You are invited to participate in the InVite Study. The InVite Study…  Read More

Fake Avastin Discovered in US

The Food and Drug Adminstration and Genentech have reported that counterfeit Avastin is being distributed in the United States. The counterfeit medicine does not contain bevacizumab, Avastin’s active ingredient. The packaging is different from genuine Avastin marketed here by Genentech. It includes a Roche logo which isn’t on the real drug, along with different codes. Avastin…  Read More

C-08 Avastin Trial Didn't Meet Primary Goal

When Avastin® (bevacizumab) was added to standard chemotherapy after surgery, it didn’t reduce the risk that early stage colon cancer would return, according to a press release this morning from Genentech. NSABP C-08 randomly assigned patients with stage II or III colon cancer to FOLFOX chemotherapy with or without additional Avastin.  During the Phase III clinical trial, all patients…  Read More